Bull & Bear

Bull and Bear

Verdict: Watchlist — the bear's evidence is stronger today, but the bull's disconfirming events are specific, dated, and arrive inside 6 months. At NT$780 the stock prices the FY26 ramp at full multiple; the franchise is real but every premium leg (margin snap-back, CPO "functional monopoly," named hyperscaler customer) is still narrative until the April-2026 MSS HG launch and the Q2-FY26 print test it. The decisive tension is whether the 4Q25 → 1Q26 margin recovery sustains and whether an actual hyperscaler-tier customer is disclosed — both observable, neither yet observed. Until the Q2 FY26 print (Aug 2026), you are paying ~50× trailing EBITDA for an option on execution; the time to commit is after the option starts to pay off, not before.

Bull Case

No Results

Bull's price target: NT$1,150 (~47% upside from NT$780). Method: 28× EV/EBITDA on FY27E EBITDA of ~NT$2.0B (FY27 revenue NT$3.5B at 35% gross margin and ~23% D&A intensity), yields EV ~NT$56B less net debt NT$1.7B = equity ~NT$54.3B ÷ 51.78M shares ≈ NT$1,048, plus a 10% premium for the named-anchor catalyst converting. Timeline: 12–18 months, anchored on the FY25 AR (~April 2026), FY26 quarterly cadence, and the MSS HG SiPh platform debut. Disconfirming signal: Quarterly operating margin remains below 10% through 1H 2026 (vs FY26 guide implying mid-teens), OR monthly revenue YoY growth lags the MA-Tek + iST average by more than 5 percentage points for two consecutive months.

Bear Case

No Results

Bear's downside target: NT$300 (~62% downside; implied market cap NT$15.5B, EV NT$16.4B). Method: 18× forward EV/EBITDA (still a 70% premium to MA-Tek's 10.7×) on FY26E EBITDA of ~NT$900M (modest improvement from TTM NT$844M, well short of bull-case operating leverage); EV NT$16.4B less net debt NT$1.67B → equity NT$14.7B ÷ 51.8M shares ≈ NT$284, rounded to NT$300. Timeline: 12–18 months, anchored on FY26 Q2 and Q3 prints (Aug 2026, Nov 2026). Cover signal: A named Nvidia/Broadcom/Marvell-tier customer publicly disclosed as a CPO inspection client, combined with quarterly gross margin sustained at 28%+ for two consecutive quarters and top-2 customer concentration falling below 40%.

The Real Debate

No Results

Verdict

Watchlist. The bear's evidence carries more weight today — a 50.3× trailing EV/EBITDA multiple with a 5× premium to a better-executing direct peer, FY25 FCF of -NT$439M, a first-ever convertible bond, governance concentrated in a founder-chairman-CEO with no Lead Independent Director, and a "functional monopoly" claim that rests on a single third-party citation. The most important tension is the second one: whether the 4Q25 → 1Q26 gross-margin recovery (13.2% → 28.6%) is the leading edge of a sustained operating-leverage cycle, or a quarter that the bear's "MA-Tek delivered 13.9% OM through the same capex wave at one-fifth the multiple" comparison ultimately wins. The bull could still be right — operating cash flow held inside a ±13% band straight through a GAAP collapse, the depreciation drag is mechanically front-loaded, and a named hyperscaler disclosure would re-categorise the stock — but every one of those legs has a specific public test date in the next two quarters. The verdict changes to Lean Long on a Q2-FY26 print (August 2026) showing gross margin above 25% and operating margin above 10%, paired with a named-customer disclosure within 12 months of the April-2026 MSS HG launch. It changes to Avoid if the Q2 print shows gross margin below 25% with revenue growth decelerating below the +30% guide, or if 12 months pass post-launch with no named hyperscaler customer.